Penny Stock Pick - RPRX
After staying in the 30 cents range for two months, shares of Repros Therapeutics(RPRX) finally break out in late August and rose to 60 cents per share following research firm upgrade on August 20. From the technical chart it shows the stock hit the resistance at the 200 day moving average and pulled back which could mean some downward pressure till the stock hit the 50 day MA of 40 cents per share. KD still indicate a bullish trend. The insider transaction also shows bullish trend as director and officer have been buying the stock in June and July between 30 to 45 cents per share. The income statement show some bullish sign as the company has reduced loss and make some revenue. However the loss is still huge so the company was still selling the stock according to the cash flow which show continuous weakness. At the point the stock is on the watch list but not a strong buy yet.